Woodline Partners »

Miragen Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 819k 22.75
2024-06-30 $5.2M 401k 13.01
2024-03-31 $7.7M 439k 17.51
2023-06-30 $4.0M 168k 23.79
2023-03-31 $3.0M 119k 25.44
2022-12-31 $9.5M 324k 29.21
2022-09-30 $6.1M 296k 20.51
2022-06-30 $6.4M 552k 11.57
2022-03-31 $4.1M 221k 18.49
2021-12-31 $5.1M 258k 19.77